Neurologic Complications of Immunotherapy

被引:0
|
作者
Schiess, Desi [1 ]
Raj, Karuna [1 ]
Shah, Bhavya [1 ]
Yu, Frank [1 ]
Agarwal, Amit [1 ]
机构
[1] UT Southwestern Med Sch, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
Immunotherapy; Neurologic Complications of Immunotherapy; Imaging of Neurologic Complications of Immunotherapy; ADVERSE EVENTS;
D O I
10.1097/01.CDR.0000661748.95847.23
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Immunotherapy enhances a patient's own immune system to fight against malignancy and has become increasingly popular during the last decade. Tumor cells can escape destruction by the patient's immune system by overexpression of immunosuppressive molecules such as cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), programmed cell death-1 (PD-1) receptor, and its ligand PD-L1. Immunotherapy agents target these inhibitors and basically reactivate the cytotoxic lymphocytes to destroy the tumor cells. Immunotherapy agents currently are FDA-approved for advanced malignancies including melanoma, Hodgkin lymphoma, head and neck squamous cell carcinoma, non-small cell lung cancer, and renal cell carcinoma. In addition, they have shown beneficial promise in the treatment of other malignancies such as high-grade gliomas.1 As of 2018, the common immune checkpoint blocking antibodies approved by the FDA for immunotherapy include ipilimumab, nivolumab, and pembrolizumab; however, exponential growth of these agents is expected in the next few years when many new agents will receive approval and cover a wider range of malignancies. Considering that immunotherapy seeks to harness the patient's own immune system to fight cancer, increased inflammatory changes are expected. The inflammatory changes may involve the skin, gastrointestinal tract, liver, endocrine, and neurologic systems and together are known as immune-related adverse events (irAEs).
引用
收藏
页码:1 / 7
页数:8
相关论文
共 50 条
  • [41] NEUROLOGIC COMPLICATIONS OF ALCOHOLISM
    RUBINO, FA
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1992, 15 (02) : 359 - 372
  • [42] NEUROLOGIC COMPLICATIONS OF POLYCYTHEMIA
    SILVERSTEIN, A
    GILBERT, H
    WASSERMAN, LR
    ANNALS OF INTERNAL MEDICINE, 1962, 57 (06) : 909 - +
  • [43] The neurologic complications of scleromyxedema
    Berger, JR
    Dobbs, MR
    Terhune, MH
    Maragos, WF
    MEDICINE, 2001, 80 (05) : 313 - 319
  • [44] Neurologic Complications of Transplantation
    Dhar, Rajat
    NEUROCRITICAL CARE, 2018, 28 (01) : 4 - 11
  • [45] NEUROLOGIC COMPLICATIONS OF IMMUNIZATIONS
    RUTLEDGE, SL
    SNEAD, OC
    JOURNAL OF PEDIATRICS, 1986, 109 (06): : 917 - 924
  • [46] NEUROLOGIC COMPLICATIONS OF MYELOMATOSIS
    SILVERSTEIN, A
    DONIGER, DE
    ARCHIVES OF NEUROLOGY, 1963, 9 (05) : 534 - &
  • [47] The neurologic complications of hemophilia
    Aggeler, PM
    Lucia, SP
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1944, 99 : 475 - 500
  • [48] DIABETES AND NEUROLOGIC COMPLICATIONS
    MIZISIN, AP
    POWELL, HC
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1990, 3 (03): : 418 - 424
  • [49] Neurologic complications of cancer
    Tasdemiroglu, E
    Kaya, AH
    Bek, S
    Emir, CB
    Sengoz, A
    Kilickesmez, O
    Mansuroglu, I
    NEUROSURGERY QUARTERLY, 2004, 14 (03) : 133 - 153
  • [50] A Concise Review of Neurologic Complications Associated with Chimeric Antigen Receptor T-cell Immunotherapy
    Ruff, Michael W.
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    NEUROLOGIC CLINICS, 2020, 38 (04) : 953 - 963